Covered recipient · General Payments record
ASHRAF Z BADROS
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$24,315.55
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,985.00 | 1 |
| Travel and Lodging | $491.10 | 2 |
| Food and Beverage | $221.74 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $4,985.00 | 1 |
| Janssen Scientific Affairs, LLC | $599.44 | 2 |
| Janssen Biotech, Inc. | $45.62 | 2 |
| Legend Biotech USA Inc. | $25.50 | 1 |
| Merck Sharp & Dohme Corporation | $24.38 | 1 |
| PFIZER INC. | $17.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GENZYME CORPORATION | $4,985.00 | 10/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139652959 | CMS |
| Janssen Biotech, Inc. | $0.85 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078707318 | CMS |
| Janssen Biotech, Inc. | $44.77 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078710338 | CMS |
| Janssen Scientific Affairs, LLC | $465.60 | 10/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1078851864 | CMS |
| Janssen Scientific Affairs, LLC | $133.84 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078851942 | CMS |
| Legend Biotech USA Inc. | $25.50 | 06/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131690083 | CMS |
| Merck Sharp & Dohme LLC | $24.38 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141803065 | CMS |
| PFIZER INC. | $17.90 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132025301 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.